Sacroiliac Joint Lidocaine Injection: Technique and Dosage
For SI joint lidocaine injections, use fluoroscopic guidance with 2 mL of 2% lidocaine injected into the inferior aspect of the joint after confirming intra-articular placement with contrast. 1
Image Guidance Requirement
Fluoroscopic guidance is mandatory for accurate SI joint injections. Palpation-guided injections have poor accuracy and should not be performed 1. Fluoroscopy allows confirmation of intra-articular needle placement and exclusion of intravascular positioning through contrast visualization prior to injectate delivery 1.
Fluoroscopic Technique
- Position the C-arm in a contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior SI joint lines, creating a lucency that represents your target 1
- If unable to superimpose the joint lines despite exploring various oblique angles, the medial joint line may correspond to the posterior aspect of the joint 1
- Access the inferior aspect of the joint preferentially, as this is where synovium is present 1
- Confirm needle placement with contrast injection before administering lidocaine
Lidocaine Dosage
Use 2 mL of 2% lidocaine for intra-articular SI joint injection 1. This is the evidence-based volume cited in multiple studies for diagnostic blocks.
Dosage Rationale
The SI joint has an estimated capacity of approximately 1.4 mL (range 0.6-2.7 mL) 1. Using 2 mL ensures adequate joint filling while recognizing that volumes beyond joint capacity will reach adjacent periarticular structures, which may actually enhance therapeutic outcomes based on evidence suggesting combined intra-articular and extra-articular injections provide increased benefit 1.
Maximum Safe Dose Considerations
Per FDA labeling, the maximum recommended dose of lidocaine without epinephrine should not exceed 4.5 mg/kg (2 mg/lb) of body weight, with a general maximum total dose of 300 mg 2. For a 2 mL injection of 2% lidocaine, you are administering 40 mg total—well below toxicity thresholds 2.
Critical Safety Considerations
Transient Sciatic Block Risk
Be aware that 6.3% of patients (8 of 127) experienced temporary sciatic nerve block following intra-articular SI joint injection with 2 mL of 2% lidocaine 1. This complication:
- May be technique-related (likely from anterior capsular disruption)
- Creates fall risk that requires patient counseling
- Is notably higher than other reported adverse event rates
- Mandates post-procedure monitoring before ambulation
Other Common Adverse Events
- Injection-site soreness (most common delayed event)
- Vasovagal reactions (2.5% incidence) 1
- Pain exacerbations
- Rare serious complications include joint infection, epidural abscess (particularly in immunosuppressed patients) 1
Diagnostic Interpretation
Immediate pain relief after lidocaine injection does NOT reliably predict subsequent therapeutic benefit. Only 54.5% of patients with 100% immediate anesthetic response achieved ≥50% pain relief at 2-4 week follow-up 3. However, patients who fail to achieve initial relief are very unlikely (negative likelihood ratio 0.0) to achieve significant pain relief at follow-up 3.
Clinical Context
Conservative therapy including over-the-counter medications and physical therapy should be attempted before proceeding to injection 1. The prevalence of true SI joint pain is only 15-30% among patients with low back pain 1, so clinical diagnosis alone is insufficient—the anesthetic block serves as the diagnostic gold standard 1.
Cephalad extension of injectate within the joint may improve outcomes, with better pain scores at 2 weeks when contrast demonstrates superior spread, though differences equalize by 8 weeks 1.